• DNA damage induced by telomere shortening resides in most quiescent HSCs.
Introduction
Telomere shortening limits the proliferative capacity of human cells and may contribute to aging-associated decline in hematopoietic stem cell (HSC) function. [1] [2] [3] [4] [5] Studies on DNA repair-deficient mice and telomerase knockout mice revealed that DNA damage accumulates in the HSC compartment and limits the functionality of HSCs by induction of DNA damage checkpoints. 6, 7 Recent studies indicated that DNA damage is repaired when HSCs enter the cell cycle. 8 However, telomere-free chromosome ends cannot easily be repaired because telomerase recruitment requires telomere repeats. 9, 10 Moreover, the formation of chromosomal fusion represents an aberrant repair pathway that interferes with maintenance of chromosomal integrity in dividing cells. 11 Whether telomere shortening-induced DNA damage leads to accumulation of DNA damage and gene expression changes in HSCs, and whether these alterations are transmitted to hematopoietic progenitor cells, is currently unknown.
Study design Animals
All mice used are C57BL/6 background. mTerc 1/2 were crossed to generate G1 mTerc 2/2
. mTerc 2/2 mice were crossed until the third generation (G3mTerc
2/2
). Mice were maintained and experiments were conducted according to protocols approved by the state government of Thuringia, Germany (Reg. No. 03-006/13).
Isolation of cells
Bone marrow cells were isolated by crushing bones from donor mice. Cells were stained and sorted by using the following surface markers combination: HSCs (CD34 ). Quiescent HSCs and cycling HSCs were purified by using Pyronin Y (P9172; Sigma-Aldrich) and Hoechst33342 (B2261; Sigma-Aldrich). Bone marrow cells were stained with antibodies for HSCs first, then incubated with Hoechst33342 (DNA dye, 1 mg/mL) at 37°C for 30 minutes and Pyronin Y (RNA dye, 100 mg/mL) for a further 15 minutes under light-free conditions. Samples were analyzed by ARIA (BD Biosciences).
Comet assays
Comet assays were conducted by using the OxiSelect Comet Assay Kit according the manufacturer's protocol. HSCs were sorted into ice-cold phosphate-buffered saline (PBS) with the concentration 1 3 10 5 cells per mL and fixed onto the OxiSelect Comet together with Comet Agarose. Then, electrophoresis was applied, and Vista Green DNA Dye was used to develop tails. The online version of this article contains a data supplement.
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(CD34 HSCs ( Figure 1A ). In contrast, the comparison of gene expression from mTerc 1/1 vs G3mTerc 2/2 revealed no differentially expressed genes at the level of MPPs and only 11 genes at the level of myeloid cells (supplemental Table 2 ; Figure 1A ). Among the 63 genes differentially expressed in HSCs from G3mTerc 2/2 compared with mTerc 1/1 mice, several DNA damagerelated or apoptosis-related genes were present (highlighted in Figure 1A ). gH2AX staining (a marker of DNA breaks) revealed a significant increase of DNA damage in freshly isolated HSCs ( Figure 1B revealed that most of the gene expression changes were present in quiescent HSCs but not in cycling HSCs (Figure 2A ; n 5 3 technical repeats, n 5 2 pools per group). The higher magnitude of gene expression changes in quiescent compared with cycling HSCs correlated with a significantly elevated rate of DNA damage foci in quiescent vs cycling HSCs from G3mTerc 2/2 compared with mTerc 1/1 mice ( Figure 2B-C) . Together, these results indicated that only the nondamaged HSCs contributed to the pool of cycling HSCs in aged telomere dysfunctional mice. One possible explanation for the results obtained is that DNA damage checkpoints were less active in quiescent HSCs compared with activated HSCs; thus, damaged HSCs were eliminated or arrested at the transition from the quiescent to the activated stage. To test this interpretation, quiescent and activated HSCs were purified by Pyronin Y and Hoechst33342 13 from 12-month-old G3mTerc
mice that were treated with interferon-a to activate quiescent HSCs to enter the cell cycle. 14 Cell cycle analysis showed significant cell cycle entry of HSCs in response to interferon-a treatment (supplemental Figure 1A-B) . To monitor the activation of DNA damage checkpoints, the expression levels of p21, 7 p16, 15 BATF, 16 and PUMA 17 were analyzed by quantitative polymerase chain reaction in freshly isolated quiescent and activated HSCs. The experiments revealed that Puma was significantly increased in cycling compared with quiescent HSCs of G3mTerc 2/2 mice ( Figure 2D ), but there was no difference for p21 and Batf expression (supplemental Figure 1G-H) . Several other apoptosis-regulating genes were also upregulated in cycling HSCs compared with quiescent HSCs from G3mTerc 2/2 mice (supplemental Figure 1C) , but not in cycling HSCs from mTerc 1/1 stimulated with interferon-a (supplemental Figure 1D ), indicating that apoptosis was induced in damaged HSCs of aged G3mTerc 2/2 mice upon activation. Furthermore, annexin-V staining revealed a significant increase in apoptosis in activated HSCs compared with quiescent HSCs of G3mTerc 2/2 mice ( Figure 2E ; supplemental Figure 1E ), but not in mTerc 1/1 mice (supplemental Figure 1F ).
The expression of p16 (a cell cycle inhibitor associated with senescence) was significantly elevated in quiescent HSCs from G3mTerc 2/2 compared with mTerc 1/1 mice, and this increase was even higher in quiescent HSCs from interferon-a stimulated G3mTerc 2/2 mice ( Figure 2F ). These data suggested that a subset of quiescent HSCs of telomere dysfunctional mice was arrested in mice from entering the cell cycle upon stimulation and generating committed progenitor cells.
This study reveals that DNA damage and gene expression changes accumulate specifically in quiescent HSCs in the context of telomere shortening. Activation of senescence locks a subset of damaged HSCs in the G0 stage, which is consistent with a recent report showing a similar phenotype in muscle stem cells from geriatric mice. 15 Some damaged HSCs from G3mTerc 2/2 mice entered the cell cycle upon stimulation, which led to apoptosis induction. Taken together, both senescence and apoptosis checkpoints may cooperate to prevent damaged HSCs from generating hematopoietic progenitor cells. A similar mechanism has been disclosed in the intestinal stem cell system. 17 In addition to the activation of checkpoints, it is also possible that DNA repair contributes to the decline of DNA damage and gene expression changes at the transition from quiescent HSCs to progenitor cells. Along these lines, a recent study showed that DNA repair signaling is compromised in quiescent HSCs but is activated when HSCs enter the cycle. 8 Of note, many of the differentially expressed genes play a role in DNA damage repair and apoptosis, which may be a response and/or contributing factor to the accumulation of DNA damage. It is conceivable that some gene expression changes are induced by chromosomal, genetic, and epigenetic alterations that occur in response to telomere dysfunction. [17] [18] [19] Together, these findings improve our understanding of the evolution and dynamics of gene expression changes and DNA damage accumulation in aging hematopoietic stem and progenitor cells in the context of telomere dysfunction. The findings may influence the selection of aberrant HSC clones that are characteristic of human aging and leukemia development. 20, 21 
